alpha1-adrenergic receptor blockers, alfuzosin, terazosin, doxazosin, tamsulosin
DISEASE INTERVENTION COMPARISON RESULTS
Int J Clin Pract. 2008 Oct;62(10):1547-59 Meta-Analysis
IN prostatic hyperplasia, benign, cardiovascular death The Use of
alpha1-adrenergic receptor blockers, alfuzosin, terazosin, doxazosin, tamsulosin
As Treatment, Chronic
Is worse Than
placebo
To modify cardivascular events: they increased it (OR 1.4 to 3.7)